High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette–Guerin therapy: A long-term survival analysis

Kai Qu(Xidian University), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Stephen B. Williams(Cedars-Sinai Medical Center), Xifeng Wu(Zhejiang Lab), Yuanqing Ye(The University of Texas MD Anderson Cancer Center), Jian Gu(Nantong University), Colin P. Dinney(The University of Texas MD Anderson Cancer Center)
OncoImmunology
January 3, 2017
10.1080/2162402x.2016.1265719
Cited by 27

Related Papers

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
|Nature Genetics|2017|804
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459